Physician profile
Nicole E Ryan
NPI 1831283548
$5,793.61
in general payments reported to CMS, 2019-2025
40 companies · $932 in 2025
The $932 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,491 · 2022: $1,368 · 2023: $1,138 · 2024: $865 · 2025: $932.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,935.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,934.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $989.83 | 2021-2025 | |
| Glaxosmithkline, LLC. | $854.81 | 2021-2025 | Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $603.83 | 2021-2024 | Jardiance |
| Astrazeneca Pharmaceuticals Lp | $443.38 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $393.57 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Lilly USA, LLC | $391.88 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $274.69 | 2021-2025 | |
| Exact Sciences Corporation | $209.05 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $201.39 | 2021-2024 | Trintellix |
| Amgen INC. | $153.11 | 2021-2024 | Otezla, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $98.91 | 2022-2024 | |
| Sanofi Pasteur INC. | $87.63 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $84.65 | 2021-2022 | |
| Dexcom, INC. | $75.66 | 2023-2025 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $72.54 | 2022-2024 | Xifaxan |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.